Significant upregulation of GP73 has been detected in the hepatocytes of patients with hepatocellular carcinoma, and therefore GP73 may present a potential novel serum marker of hepatocellular carcinoma (21–28). The gene discussed is GOLM1; the disease is hepatocellular carcinoma.